ProCE Banner Activity

Managing the Toxicities of TROP2 Antibody–Drug Conjugates in Lung Cancer

PDF

Download this expert-authored infographic with best practices for identifying and managing key toxicities associated with TROP2 ADCs in lung cancer care.

Released: April 24, 2023

Share

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.